Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Increases By 96.6%

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a large increase in short interest in July. As of July 15th, there was short interest totaling 9,443 shares, an increase of 96.6% from the June 30th total of 4,802 shares. Based on an average daily volume of 54,956 shares, the short-interest ratio is currently 0.2 days.

Alpha Tau Medical Trading Down 10.2%

Shares of NASDAQ:DRTSW opened at $2.29 on Thursday. The business’s fifty day moving average price is $2.70 and its two-hundred day moving average price is $1.66. Alpha Tau Medical has a one year low of $0.20 and a one year high of $4.28.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.